Medical - Mohit Shah - Oct 13,2017

Rating -

stars - based on 21 reviews

demand for thrombectomy devices prominent across hospitals and surgical centers

The global thrombectomy devices market is projected to increment at a CAGR of 6.1% during the period between 2017 and 2022. 

Thrombectomy devices are used for the treatment of stroke and are actively used across hospitals and surgical centers. It has been analyzed that, ongoing technological advancements in minimally invasive surgeries, improving healthcare infrastructure in a number of emerging economies and favorable reimbursement policies are some of the key factors supplementing the demand for thrombectomy devices.

Furthermore, as per active report analytics, increasing acquisition or collaboration of small specialized hospitals by tier-1 hospitals along with increasing prevalence of cerebrovascular and cardiovascular diseases are some major drivers boosting the global thrombectomy devices market. It is also projected that the concerned market would augment at a CAGR of 6.1% during the period until 2022. 

There are several fresh opportunities in the market for thrombectomy devices which are expected to support the process of market expansion. Increasing number of research activities in the field of thrombectomy and varying application of ultrasound in vascular treatment is seen as prime justifications for opening new gates.

The market consists of different product variations such as aspiration, ultrasonic, hydrodynamic and mechanical. Among these, the demand for aspiration thrombectomy devices is the quite high all across the globe. North America is the most prosperous market for thrombectomy devices and is likely to remain as an attractive hub for manufacturers during the coming years. The United States manages the largest market concentration in North America since spending on healthcare and a higher level of awareness are quite noticeable.

The efforts of the key players are quite visible since the thrombectomy devices market is steadily moving ahead. Some of the key players operating in this sector are Argon Medical Devices Inc., Medtronic PLC, Boston Scientific Corporation, BTG International Ltd., Terumo Corporation, Johnson & Johnson and Edwards Lifesciences Corporation.


For more information on this report visit-